Joincare Pharmaceutical's low P/E ratio is due to its foreca...
Joincare Pharmaceutical's low P/E ratio is due to its forecasted growth being below market average. Investors are paying less for the stock due to limited future growth expectations.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000183801109a1f4d.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment